Adamax / ADMAX
Synthetic peptide derivative
Overview
Adamax (Ac-MEHFPGPAG-NH2) is a synthetic peptide derivative that is a designer analogue of semax, described as semax modified with the N-terminal and C-terminal modifications found in Peptide 021. It has been identified as a designer drug in border seizures and has been suggested to be classified as a prescription medicine in New Zealand.
Source: English Wikipedia, "Adamax".